Clofoctol and sorafenib inhibit prostate cancer growth via synergistic induction of endoplasmic reticulum stress and UPR pathways

DOI: 10.2147/CMAR.S175256

Keywords: drug combination, endoplasmic reticulum stress, unfolded protein response, prostate cancer, clofoctol

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text